RNA-seq
Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay
The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow.
Scipher Medicine Raises $82M in Series C Financing
Scipher will use the proceeds to further commercialize PrismRA, a molecular test intended to guide treatment decisions for patients with rheumatoid arthritis.
NeoGenomics, Elevation Oncology Partner on NRG1 Fusion Testing for Clinical Trial Enrollment
NeoGenomics will use its gene fusion panels to identify patients with solid tumors and an NRG1 fusion who might qualify for Elevation's Phase II CRESTONE study.Â
Veracyte Q3 Revenues Flat but Beat Analyst Estimates
Veracyte reported total Q3 revenues of $31.1 million compared to $31.0 million in Q3 2019, beating analysts' average of $23.9 million.
Johns Hopkins-Led Team Launches Startup to Tackle Breast Cancer, Glioblastoma Applications
The team published data on Monday highlighting its microfluidic chip's ability to help predict the clinical outcomes of glioblastoma patients.Â